---
title: "TRANSTHERA-B plummeted 17% with a surge in trading volume as the six-month lock-up period for the base investors expired"
description: "TRANSTHERA-B's stock price plummeted by 17%, with trading volume surging. The six-month lock-up period for cornerstone investors has expired, leading to increased stock price volatility"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/270581377.md"
published_at: "2025-12-23T06:55:19.000Z"
---

# TRANSTHERA-B plummeted 17% with a surge in trading volume as the six-month lock-up period for the base investors expired

> TRANSTHERA-B's stock price plummeted by 17%, with trading volume surging. The six-month lock-up period for cornerstone investors has expired, leading to increased stock price volatility

TRANSTHERA-B (02617.HK) opened down 1.7% this morning (23rd) and the decline expanded, dropping as much as 18.8% to a low of 137 HKD. In the afternoon, it was last reported at 140 HKD, down 17.01%, with trading volume increasing to 2.008 million shares, involving 294 million HKD.

The company was listed on June 23 at a price of 13.15 HKD per share, and the six-month lock-up period for cornerstone investors expires today. The stock had surged over 50 times in less than three months after its listing, reaching a high of 679.5 HKD before closing lower on the same day. At the current price, it is still more than 9.6 times higher than the listing price

### Related Stocks

- [02617.HK - TRANSTHERA-B](https://longbridge.com/en/quote/02617.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 港股异动：基石投资者解禁引发担忧，药捷安康-B 股价暴跌 16.36% | 药捷安康-B 跌 16.36%；信达生物涨 0.92%，成交额达到 2.51 亿港币；三生制药涨 1.68%，成交额达到 1.83 亿港币；荣昌生物涨 0.92%，成交额达到 1.37 亿港币；百济神州涨 0.43%，市值达到 2889 亿 | [Link](https://longbridge.com/en/news/270561769.md) |
| 港股异动：药捷安康-B 涨 16.21%，资金流向活跃，板块趋势引发市场关注？ | 药捷安康-B 涨 16.21%；三生制药跌 1.44%，成交额达到 1.3 亿港币；信达生物跌 1.01%，成交额达到 1.17 亿港币；康方生物跌 1.52%，成交额达到 70.04 百万港币；百济神州跌 1.14%，市值达到 2799  | [Link](https://longbridge.com/en/news/271050704.md) |
| 一场由减肥 “神药” 引发的 “甜味危机”：糖价腰斩，连梦龙也卖不动了！ | GLP-1 类减肥药正通过改变饮食行为，重塑糖与蛋白质的需求结构，并迅速传导至期货与股票市场。纽约原糖期货跌破 14 美分，创 2020 年以来新低，较 2023 年末高点腰斩。全球最大冰淇淋公司梦龙在销量不及预期后股价大跌，引发对冰淇淋等 | [Link](https://longbridge.com/en/news/275766631.md) |
| 港股异动：基石投资者解禁重压药捷安康-B，股价暴跌 16.6% | 药捷安康-B 跌 16.60%；信达生物跌 0.43%，成交额达到 3.91 亿港币；三生制药涨 0.69%，成交额达到 2.55 亿港币；康方生物跌 1.13%，成交额达到 2.34 亿港币；百济神州跌 1.39%，市值达到 2836 亿 | [Link](https://longbridge.com/en/news/270574834.md) |
| 胜捷住宿房地产投资信托为西雅乌美项目增加床位 \| 联合早报网 | 胜捷住宿房地产投资信托获得临时准证，在西雅乌美额外发展一栋六层建筑，并对现有八层高建筑进行改造，床位数量将从 1650 增至 2190。工程预计在今年第二季开始，约一年半内完成，现有建筑将继续运营并贡献收入。信托股价下跌 1.75% 至 1 | [Link](https://longbridge.com/en/news/275481119.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.